No 'Safe Harbor' For Gene Therapy Found In Hatch-Waxman
A Delaware federal judge told Massachusetts biotechnology company Sarepta on Tuesday that it could not use the "safe harbor" provisions of the Hatch-Waxman Act to protect a gene therapy it is...To view the full article, register now.
Already a subscriber? Click here to view full article